Latest News

Matthew D. Czech, PhD, associate director of digital science at AbbVie
Digital Health Technologies Superior to Traditional Approaches for Measuring Disease Progression in Early Parkinson Disease

March 28th 2024

A recent study revealed that digital composite measures for bradykinesia outperformed traditional assessment methods for Parkinson disease over a 12-month period.

High Dose PRAX-628 Achieves Complete Response in Phase 2a Study of Photo Paroxysmal Response
High Dose PRAX-628 Achieves Complete Response in Phase 2a Study of Photo Paroxysmal Response

March 28th 2024

Nuno Mendonca, MD, chief medical officer at AC Immune SA
AC Immune SA Shares Phase 2 VacSYn Trial Update for ACI-7104.056 in Parkinson Disease

March 28th 2024

Satralizumab Fails to Reach Expected Clinical Benefit in LUMINESCE Study of Myasthenia Gravis
Satralizumab Fails to Reach Expected Clinical Benefit in LUMINESCE Study of Myasthenia Gravis

March 27th 2024

NeuroVoices: Danielle Andrade, MD, MSc, FRCPC, on Challenges in the Transition from Pediatric to Adult Epilepsy Care
NeuroVoices: Danielle Andrade, MD, MSc, FRCPC, on Challenges in the Transition from Pediatric to Adult Epilepsy Care

March 27th 2024

ACTRIMS 2024
MDA 2024
Roundtable Discussions
NeuroVoices
Mind Moments podcast
Sleeping Around the Podcast with Dr. Ann Marie Morse
Gold Standard Centers
EEGTalk with Fabio Nascimento, MD, and Brandon Westover, MD, PhD
Brain Games

Conference Coverage

View All
Aki Ko, chief executive officer at Elixirgen Therapeutics
Elixirgen Therapeutics’ Bobcat mRNA Therapeutic for Duchenne Muscular Dystrophy: Aki Ko

March 28th 2024

Nuno Mendonca, MD, chief medical officer at AC Immune SA
AC Immune SA Shares Phase 2 VacSYn Trial Update for ACI-7104.056 in Parkinson Disease

March 28th 2024

Le Hua, MD
Analyzing Cognitive Profiles in Multiple Sclerosis and Alzheimer Disease: Le Hua, MD

March 27th 2024

Amanda Peltier, MD
Integrating Genetics and Transitional Support in Muscular Dystrophy Care: Amanda Peltier, MD

March 27th 2024

Video Series
Video Interviews
Podcasts

Most Recent

© 2024 MJH Life Sciences

All rights reserved.